Session R.a. Ii - Net Worth and Insider Trading
Session R.a. Ii Net Worth
The estimated net worth of Session R.a. Ii is at least $24 Million dollars as of 2024-05-15. Session R.a. Ii is the 10% Owner of Taysha Gene Therapies Inc and owns about 9,153,927 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $24 Million. Details can be seen in Session R.a. Ii's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Session R.a. Ii has not made any transactions after 2023-07-13 and currently still holds the listed stock(s).
Transaction Summary of Session R.a. Ii
Session R.a. Ii Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Session R.a. Ii owns 4 companies in total, including Taysha Gene Therapies Inc (TSHA) , Chardan Healthcare Acquisition 2 Corp (CHAQ.U) , and AveXis Inc (AVXS) among others .
Click here to see the complete history of Session R.a. Ii’s form 4 insider trades.
Insider Ownership Summary of Session R.a. Ii
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-07-13 | 10 percent owner |
| CHAQ.U | Chardan Healthcare Acquisition 2 Corp | 2020-04-23 | director |
| AVXS | AveXis Inc | 2018-05-15 | Sr. VP & Corp Strategy |
 | | 2020-04-23 | director |
Session R.a. Ii Latest Holdings Summary
Session R.a. Ii currently owns a total of 1 stock. Session R.a. Ii owns 9,153,927 shares of Taysha Gene Therapies Inc (TSHA) as of July 13, 2023, with a value of $24 Million.
Latest Holdings of Session R.a. Ii
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-07-13 | 9,153,927 | 2.57 | 23,525,592 |
Holding Weightings of Session R.a. Ii
Session R.a. Ii Form 4 Trading Tracker
According to the SEC Form 4 filings, Session R.a. Ii has made a total of 4 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Taysha Gene Therapies Inc is the sale of 85,872 shares on July 13, 2023, which brought Session R.a. Ii around $60,969.
Insider Trading History of Session R.a. Ii
- 1
Session R.a. Ii Trading Performance
GuruFocus tracks the stock performance after each of Session R.a. Ii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Session R.a. Ii is -53.58%. GuruFocus also compares Session R.a. Ii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Session R.a. Ii within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Session R.a. Ii's insider trading performs compared to the benchmark.
Performance of Session R.a. Ii
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.7 | | | | | |
| Relative Return to S&P 500(%) | -1.45 | | | | | |
Session R.a. Ii Ownership Network
Session R.a. Ii Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Session R.a. Ii is the 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Astellas Pharma Inc. .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Session R.a. Ii made 3 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net sale of 549,095. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 16,566,667 shares made by Paul B Manning , a net purchase of 777,778 shares made by Stalfort John A Iii , and a net purchase of 444,444 shares made by Sean P. Nolan .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 17,905,000 shares were bought by its insiders, resulting in a net purchase of 17,322,905 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Session R.a. Ii Mailing Address
Above is the net worth, insider trading, and ownership report for Session R.a. Ii. You might contact Session R.a. Ii via mailing address: C/o Avexis, Inc., 2275 Half Day Road, Suite 200, Bannockburn Il 60015.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
